Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Medulloblastoma × Temozolomide × Clear all

Phase

Phase 1 12 Phase 2 9 Phase 1/2 6 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 8 Recurrence 3 Astrocytoma 3 Gliosarcoma 2 Spinal Cord Neoplasms 1 Pituitary Neoplasms 1 Oligodendroglioma 1 Non Small Cell Lung Cancer Metastatic 1 Melanoma 1 Medulloblastoma 1 Glioma 1 Ependymoma 1 Brain Neoplasms 1

Interventions

trofosfamide 1 Thiotepa 1 Temozolomide 1 Etoposide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00749723 2018-07-20

HIT-REZ-2005

University Hospital, Bonn

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡